HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Aug 8, 2021 (Letter of inquiry)

Later deadlines: Sep 8, 2021 (Full proposal)

Grant amount: Up to US $2,075,000

Fields of work: Drug Abuse Medical Technology & Devices

Applicant type: For-Profit Business

Funding uses: Biomedical, Behavioral

Location of project: United States

Location of residency: United States

Overview:

NOTE: 

  • Applications are due by 5 p.m. submitter's local time.
  • Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

This Funding Opportunity Announcement (FOA), issued by the National Institutes on Drug Abuse (NIDA), invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications to develop technologies to provide science- and research-based solutions to the national opioid crisis and offer new hope for individuals, families, and communities affected by this devastating crisis. United States SBCs that have the research capabilities and technological expertise to contribute to NIDA R and D mission identified in this FOA are encouraged to submit SBIR grant applications in response to the FOA topics.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities

This page was last reviewed December 18, 2018 and last updated December 18, 2018